112
Participants
Start Date
October 29, 2024
Primary Completion Date
June 1, 2026
Study Completion Date
June 1, 2026
Human Serum Albumin Infusion for LAT Group
Participants in this group will receive human serum albumin infusion when their serum albumin level falls below 25 g/L. The infusion is goal-oriented, with the aim of maintaining albumin levels above 25 g/L during the postoperative period. The dose is calculated based on the albumin deficit and patient weight to ensure optimal therapeutic effect.
Human Serum Albumin Infusion for HAT Group
Participants in this group will receive human serum albumin infusion when their serum albumin level falls below 30 g/L. The intervention aims to maintain albumin levels above 30 g/L during the postoperative period. The dose is similarly calculated based on the albumin deficit and patient weight.
RECRUITING
First Hospital of Jilin University, Changchun
The First Hospital of Jilin University
OTHER